Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Nested PCR amplicons

    Our PCR protocol requires nested PCR in order to be more sensitive. We would like to amplicon sequence such nested PCR fragments but we were wondering how much 'bias' it would be introduced by the second round PCR? Would this favor amplification of major variants and 'elimination' of the minors just because of the frequency of each variant, thus reducing the complexity (number of haplotypes) after deep sequencing?
    Has anyone tryed amplicon sequence nested amplicons?
    Is it recommended by Roche?
    Last edited by AEscobar; 06-30-2010, 12:31 PM.

  • #2
    Roche is extremely circumspect in these matters--they will not have officially offered an opinion one way or another.

    In any case you have articulated a concern. Seems like a reasonable concern to me. You can test whether there is a problem using spike in experiments.

    Or validate any results you see using another method afterwards.
    --
    Phillip

    Comment


    • #3
      pmiguel

      Thanks for your reply!
      You can test whether there is a problem using spike in experiments.

      Or validate any results you see using another method afterwards.
      Would you mind providing more details about both suggestions?

      Comment


      • #4
        Originally posted by AEscobar View Post
        Thanks for your reply!

        Would you mind providing more details about both suggestions?
        Sure. But I am more or less stating the obvious. Please don't expect any deep insights here.

        In a spike in experiment you add known amounts of sample from a known source at at different levels of dilution to your assay. If your assay faithfully reflects those known levels then you have reason to suspect that it will also do so for the samples you wish to test.

        A comprehensive spike in test would likely be difficult to design. So many instead go the validation route. In this route you trust your new, untested, assay only to provide candidates for assays that are known to be reliable. That is, you might use an RNA seq experiment to "scan" through the transcriptomes of your samples under conditions of interest. Then based on an arbitrary threshold (say the 10 transcripts showing the highest variation (fold change) under the conditions you are studying) you choose candidates for further testing. For example test their levels specifically using qPCR.

        The advantage of this method is that you can use powerful new technologies for "descriptive" rather than analytical purposes. Then you don't need to validate the new technologies up front yet you can benefit from their power.

        --
        Phillip

        Comment


        • #5
          Thanks!

          We are already designing an experiment where we will be using some of our plasmids as controls.

          Comment

          Latest Articles

          Collapse

          • seqadmin
            Genetic Variation in Immunogenetics and Antibody Diversity
            by seqadmin



            The field of immunogenetics explores how genetic variations influence immune responses and susceptibility to disease. In a recent SEQanswers webinar, Oscar Rodriguez, Ph.D., Postdoctoral Researcher at the University of Louisville, and Ruben Martínez Barricarte, Ph.D., Assistant Professor of Medicine at Vanderbilt University, shared recent advancements in immunogenetics. This article discusses their research on genetic variation in antibody loci, antibody production processes,...
            11-06-2024, 07:24 PM
          • seqadmin
            Choosing Between NGS and qPCR
            by seqadmin



            Next-generation sequencing (NGS) and quantitative polymerase chain reaction (qPCR) are essential techniques for investigating the genome, transcriptome, and epigenome. In many cases, choosing the appropriate technique is straightforward, but in others, it can be more challenging to determine the most effective option. A simple distinction is that smaller, more focused projects are typically better suited for qPCR, while larger, more complex datasets benefit from NGS. However,...
            10-18-2024, 07:11 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by seqadmin, Today, 06:13 AM
          0 responses
          9 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 11-01-2024, 06:09 AM
          0 responses
          30 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 10-30-2024, 05:31 AM
          0 responses
          21 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 10-24-2024, 06:58 AM
          0 responses
          26 views
          0 likes
          Last Post seqadmin  
          Working...
          X